Personal HistoryMark H. Flasar, M.D.,M.S. is a board certified Gastroenterologist and Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, at the University of Maryland School of Medicine in Baltimore, Maryland. He also serves as Associate Director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine in Baltimore and is a staff physician in the GI section at the Veterans Affairs, Maryland Health Care System Baltimore.
Dr. Flasar, raised in neighboring Prince George's County, received his undergraduate Bachelor's of Science Degree (Psychology with Honors) from the University of Maryland in College Park, Maryland in 1996. Subsequently, he earned his medical degree from the University of Maryland School of Medicine in Baltimore, Maryland in 2000. In 2003, he completed his postgraduate training in Internal Medicine at Duke University and Durham VA Medical Center in Durham, North Carolina. After spending a year on faculty at the University of Maryland School of Medicine as a hospitalist on the Transplant Medicine Inpatient Service, he completed his Gastroenterology and Hepatology fellowship training at the University of Maryland and Baltimore VA Medical Centers in 2004. During his fellowship, he recieved additional focused training in Inflammatory Bowel Diseases at the Hospitals of the University of North Carolina in Chapel Hill. In addition, Dr. Flasar has obtained a Master of Science degree in Clinical Research at the University of Maryland School of Medicine, Department of Epidemiology and Preventive Medicine, in Baltimore.
Research InterestsEpidemiology and Natural History of IBD; Racial Disparities; Therapeutic Clinical Trials
Clinical SpecialityInflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis
Flasar MH, Goldberg E. Abdominal Pain. 2006. Med Clin North Am;90(3):481-503.
Flasar MH, Cross R, Goldberg E. Abdominal Pain. 2006. Prim Care;33(3):659-684.
Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008 Jan;14(1):13-9.
Flasar MH, Quezada S, Bijpuria P, Cross RK. Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study. Dig Dis Sci. 2008 Feb 14; [Epub ahead of print]
Flasar, M, Roghmann, MC, and Cross, RK. Response to Disparities in IBD Care: Time to Correct a Problem. Gastroenterol 2008:134(5);1618-19.
Flasar M, Harris A, Hungerford L, Cross R. Risk of Lymphoma in Inflammatory Bowel Disease (IBD); a Systematic Qualitative Review. Gastroenterol 2005;128(4):A-319.
Khurana S, Flasar MH. Factors Affecting Hepatic Venous Pressure Gradient (HVPG) in Patients with Chronic Hepatitis C. Gastroenterol 2007;132(4):A-797.
Flasar M, Morgan D, Isaacs K. Video Capsule Endoscopy in Patients with Obstructing Disease: Experience from A Tertiary Referral Center. Am J Gastroenterol 2007;102(S2):1140.
Khurana S, Flasar MH. The Effect of Dialysis on Hepatic Venous Pressure Gradient in Patients with Chronic Hepatitis C, Gastroenterol 2008; 134(4S1):A812
Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of Medical Treatment of Stricturing and Fistulizing Crohn's Disease: A Retrospective Study. Am J Gastroenterol 2008; in press.
Links of InterestUMMC Inflammatory Bowel Disease (IBD) Program
Faculty members: Update your contact information and create a profile.